Palbace 125 mg Capsule

Get a Price/Quote

Palbace 125 mg Capsule Specification

Pacakaging (Quantity Per Box)
1 pack containing 21 capsules

Salt Composition
Palbociclib 125 mg

Origin of Medicine
Synthetic

Drug Type
Anti-cancer medication

Ingredients
Palbociclib

Physical Form
Capsule

Function
To inhibit cancer cell growth by targeting specific proteins required for cancer cell division

Recommended For
Patients with breast cancer particularly hormone receptor-positive and HER2-negative advanced or metastatic breast cancer

Dosage
125 mg once daily for 21 days followed by 7 days off therapy (28-day cycle)

Dosage Guidelines
Take with food as directed by a healthcare professional; do not crush or chew capsules

Suitable For
Adults

Quantity
21 capsules per pack

Storage Instructions
Store at room temperature between 20-25C (68-77F) protect from moisture and light

About Palbace 125 mg Capsule

Palbace 125 mg Capsule is an anti-cancer medication suitable for adults, specifically indicated for patients with hormone receptor-positive and HER2-negative advanced or metastatic breast cancer. Each pack contains 21 capsules of synthetic Palbociclib 125 mg to be taken once daily for 21 days followed by 7 days off therapy, forming a 28-day cycle. It functions by inhibiting cancer cell growth through targeting specific proteins essential for cancer cell division. It should be stored at room temperature, protected from moisture and light, and taken with food as directed by a healthcare professional without crushing or chewing the capsules.

FAQs of Palbace 125 mg Capsule:

Q: How should Palbace 125 mg Capsule be stored?

A: Palbace 125 mg Capsule should be stored at room temperature between 20-25C (68-77F) and protected from moisture and light.

Q: What is the recommended dosage of Palbace 125 mg Capsule?

A: The recommended dosage of Palbace 125 mg Capsule is 125 mg once daily for 21 days followed by 7 days off therapy in a 28-day cycle.

Q: For whom is Palbace 125 mg Capsule suitable?

A: Palbace 125 mg Capsule is suitable for adults, especially for patients with breast cancer, particularly hormone receptor-positive and HER2-negative advanced or metastatic breast cancer.